There's a Medicare prescription-drug coverage abyss that is playfully referred to as the "doughnut hole," though there is nothing sweet or amusing about it.
There's a Medicare prescription-drug coverage abyss that is playfully referred to as the "doughnut hole," though there is nothing sweet or amusing about it.
But thanks to the Affordable Care Act, which had a rocky launch last week, Medicare beneficiaries will see that gap shrink again in 2014 and in each year until 2020, according to Medicare.gov.
The doughnut hole is the temporary limit on what Medicare drug plans pay after certain dollar thresholds for drugs have been met.
The year starts with monthly Part D premiums and a $310 deductible. You pay 100% of drug costs until hitting the deductible. Then, out-of-pocket costs—consider those copays—drop to 25% of the price of your medications. The plan pays the rest until you reach a ceiling of $2,850 in combined payments by you and the plan.
Read the full story here: http://on.wsj.com/1a4WExD
Source: Wall Street Journal
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Closing the Gaps in Cardiac Care With Technology, Collaboration
March 12th 2025Cardiologists, primary care physicians, and value-based care leaders convened in Phoenix, Arizona, on November 12, 2024, to share case studies and insights on how to align cardiology with the principles of value-based care, including through the application of digital tools.
Read More